Fish oil: What the prescriber needs to know

Arthritis Research and Therapy

Volumn 8, Issue 1, 2006, Pages

  Cleland, Leslie G ^a   James, Michael J ^a   Proudman, Susanna M ^a  

^a ROYAL ADELAIDE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ARACHIDONIC ACID; COD LIVER OIL; CYCLOOXYGENASE 2 INHIBITOR; CYCLOSPORIN; DOCOSAHEXAENOIC ACID; FISH OIL; HYDROXYCHLOROQUINE; ICOSAPENTAENOIC ACID; LINOLEIC ACID; LINOLENIC ACID; METHOTREXATE; METHYLMERCURY; MONOUNSATURATED FATTY ACID; NONSTEROID ANTIINFLAMMATORY AGENT; OLEIC ACID; OMEGA 3 FATTY ACID; POLYCHLORINATED BIPHENYL; POLYUNSATURATED FATTY ACID; PROSTAGLANDIN E2; SALAZOSULFAPYRIDINE; WARFARIN;

ANTIINFLAMMATORY ACTIVITY; BLEEDING TENDENCY; BODY WEIGHT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CROHN DISEASE; DIARRHEA; DIETARY INTAKE; DOSE RESPONSE; DRUG COST; DRUG HYPERSENSITIVITY; DRUG MECHANISM; DRUG STRUCTURE; GASTROINTESTINAL SYMPTOM; HEADACHE; HEART INFARCTION; HUMAN; HYPERTENSION; LIPID PEROXIDATION; NEPHROTOXICITY; NOCICEPTION; PREGNANCY; PRESCRIPTION; PROSTAGLANDIN SYNTHESIS INHIBITION; REVIEW; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; TASTE DISORDER; ARTHRITIS; ARTICLE; DECISION MAKING; PHYSICIAN; REPRODUCIBILITY;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTHRITIS; ARTHRITIS, RHEUMATOID; DECISION MAKING; FISH OILS; HUMANS; PHYSICIANS; REPRODUCIBILITY OF RESULTS;

EID: 33144458200     PISSN: 14786354     EISSN: None     Source Type: Journal    
DOI: 10.1186/ar1876     Document Type: Review

References (63)

1. Cleland LG, Gibson RA, Hawkes JS, James MJ: Comparison of cell membrane phospholipid fatty acids in five rat strains fed four test diets. Lipids 1990, 25:559-564.
2. Lands WEM, Libelt B, Morris A, Kramer NC, Prewitt TE, Bowen P, Schmeisser D, Davidson MH, Burns JH: Maintenance of lower proportions of (n-6) eicosanoid precursors in phospholipids of human plasma in response to added dietary (n-3) fatty acids. Biochim Biophys Acta 1992, 1180:147-162.
3. Cleland LG, James MJ, Neumann MA, D'Angelo M, Gibson RA: Linoleate inhibits EPA incorporation from dietary fish oil supplements in human subjects. Am J Clin Nutr 1992, 55:395-399.
4. Mantzioris E, James MJ, Gibson RA, Cleland LG: Dietary substitution with an a-linolenic acid-rich vegetable oil increases eicosapentaenoic acid concentrations in tissues. Am J Clin Nutr 1994, 59:1304-1309.
5. James MJ, Ursin VM, Cleland LG: Metabolism of stearidonic acid in human subjects: comparison with the metabolism of other n-3 fatty acids. Am J Clin Nutr 2003, 77:1140-1145.
6. James MJ, Gibson RA, Cleland LG: Dietary polyunsaturated fatty acids and inflammatory mediator production. Am J Clin Nutr 2000, Suppl:343S-348S.
7. James MJ, Cleland LG: Dietary n-3 fatty acids and therapy for rheumatoid arthritis. Semin Arthritis Rheum 1997, 27:85-97.
8. Cleland LG, James MJ, Proudman SM: The role of fish oils in the treatment of rheumatoid arthritis. Drugs 2003, 63:845-853.
9. Skoldstam L, Borjesson O, Kjallman A, Seiving B, Akesson B: Effect of six months of fish oil supplementation in stable rheumatoid arthritis. A double blind, controlled study. Scand J Rheumatol 1992, 21:178-185.
10. Lau CS, Morley KD, Belch JJF: Effects of fish oil supplementation on non-steroidal anti-inflammatory drug requirement in patients with mild rheumatoid arthritis - a double blind placebo controlled study. Br J Rheumatol 1993, 32:982-989.
11. Geusens P, Wouters C, Nijs J, Jiang Y, Dequeker J: Long-term effect of omega-3 fatty acid supplementation in active rheumatoid arthritis. Arthritis Rheum 1994, 37:824-829.
12. Caughey GE, Cleland LG, Penglis PS, Gamble JR, James MJ: Roles of Cyclooxygenase (COX) -1 and -2 in prostanoid production by human endothelial cells: selective upregulation of prostacyclin synthesis by COX-2 J Immunol 2001, 167:2831-2838.
13. McAdam BF, Catella-Lawson F, Mardini IA, Kapoor S, Lawson JA, Fitzgerald GA: Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: The human pharmacology of a selective inhibitor of COX-2. Proc Natl Acad Sci USA 1999, 96: 272-277.
14. Catella-Lawson F, McAdam B, Morrison BW, Kapoor S, Kujubu D, Antes L, Lasseter KC, Quan H, Gertz BJ, Fitzgerald GA: Effects of specific inhibition of cyclooxygenase-2 on sodium balance, hemodynamics, and vasoactive eicosanoids. J Pharmacol Exp Ther 1999, 289:735-741.
15. Solomon DH: Selective cyclooxygenase 2 inhibitors and cardiovascular events. Arthritis Rheum 2005, 52:1968-1978.
16. Cleland LG, French JK, Betts WH, Murphy GA, Elliott M: Clinical and biochemical effects of dietary fish oil supplements in rheumatoid arthritis. J Rheumatol 1988, 15:1471-1475.
17. Cleland LG, James MJ, Gibson RA, Hawkes JS, Betts WH: Effect of dietary oils on the production of n-3 and n-6 metabolites of leukocyte 5-lipoxygenase in five rat strains. Biochim Biophys Acta 1990, 1043:253-258.
18. 2 in non-adherent human monocytes. J Immunol 1997, 158:351-358.
19. Mantzioris E, Cleland LG, Gibson RA, Neumann MA, Demasi M, James MJ: Biochemical effects of a diet containing foods enriched with n-3 fatty acids. Am J Clin Nutr 2000, 72:42-48.
20. Endres S, Ghorbani R, Kelley VE, Georgilis K, Lonnemann G, van der Meer JW, Cannon JG, Rogers TS, Klempner MS, Weber PC, et al.: The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. N Engl J Med 1989, 320:265-271.
21. Meydani S, Endres S, Woods MM, Goldin BR, Soo C, Morrill-Labrode A, Dinarello CA, Gorbach SL: Oral (n-3) fatty acid supplementation suppresses cytokine production and lymphocyte proliferation: comparison between younger and older women. J Nutr 1991, 121:547-555.
22. Demasi M, Cleland LG, Cook-Johnson RJ, Caughey GE, James MJ: Effects of hypoxia on monocyte inflammatory mediator production: dissociation between changes in cyclooxygenase-2 expression and eicosanoid synthesis. J Biol Chem 2003, 278:38607-38616.
23. Kremer JM, Lawrence DA, Jubiz W, DiGiacomo R, Rynes R, Bartholomew LE, Sherman M: Dietary fish oil and olive oil supplementation in patients with rheumatoid arthritis. Arthritis Rheum 1990, 33:810-820.
24. Belluzzi A, Brignola C, Campieri M, Pera A, Boschi S, Miglioli M: Effect of an enteric-coated fish-oil preparation on relapses in Crohn's disease. N Engl J Med 1996, 334:1557-1560.
25. Donadio JV Jr, Bergstralh EJ, Offord KP, Spencer DC, Holley KE: A controlled trial of fish oil in IgA nephropathy. Mayo Nephrology Collaborative Group. N Engl J Med 1994, 331:1194-1199.
26. Duffy EM, Meenagh GK, McMillan SA, Strain JJ, Hannigan BM, Bell AL: The clinical effect of dietary supplementation with omega-3 fish oils and/or copper in systemic lupus erythematosus. J Rheumatol 2004, 31:1551-1556.
27. Robinson DR, Xu LL, Tateno S, Guo M, Colvin RB: Suppression of autoimmune disease by dietary n-3 fatty acids. J Lipid Res 1993, 34:1435-1444.
28. Denke MA: Dietary retinol: a double-edged sword. JAMA 2002, 287:102-104.
29. Horowitz M, Jones K, Edelbroek MA, Smout AJ, Read NW: The effect of posture on gastric emptying and intragastric distribution of oil and aqueous meal components and appetite. Gastroenterology 1993, 105:382-390.
30. Ruzickova J, Rossmeisl M, Prazak T, Flachs P, Sponarova J, Veck M, Tvrzicka E, Bryhn M, Kopecky J: Omega-3 PUFA of marine origin limit diet-induced obesity in mice by reducing cellularity of adipose tissue. Lipids 2004, 39:1177-1185.
31. Barrett JH, Brennan P, Fiddler M, Silman A: Breast-feeding and postpartum relapse in women with rheumatoid and inflammatory arthritis. Arthritis Rheum 2000, 43:1010-1015.
32. Makrides M, Gibson RA: Long-chain polyunsaturated fatty acid requirements during pregnancy and lactation. Am J Clin Nutr 2000, Suppl:307S-311S.
33. Olsen SF, Grandjean P, Weihe P, Videro T: Frequency of seafood intake in pregnancy as a determinant of birth weight: evidence for a dose dependent relationship. J Epidemiol Community Health 1993, 47:436-440.
34. Uauy R, Hoffman DR: Essential fat requirements of preterm infants. Am J Clin Nutr 2000, ASuppl:245S-250S.
35. Knapp HR, FitzGerald GA: The antihypertensive effects of fish oil. A controlled study of polyunsaturated fatty acid supplements in essential hypertension. N Engl J Med 1989, 320: 1037-1043.
36. Geleijnse JM, Giltay EJ, Grobbee DE, Donders AR, Kok FJ: Blood pressure response to fish oil supplementation: metaregression analysis of randomized trials. J Hypertens 2002, 20:1493-1499.
37. Grieve EM, Hawksworth GM, Simpson JG, Whiting PH: The reversal of experimental cyclosporin A nephrotoxicity by thromboxane synthetase inhibition. Biochem Pharmacol 1993, 45:1351-1354.
38. Stoof TJ, Korstanje MJ, Bilo HJ, Starink TM, Hulsmans RF, Donker AJ: Does fish oil protect renal function in cyclosporin-treated psoriasis patients? J Intern Med 1989, 226:437-441.
39. Mitsugi K, Nakamura T, Kashiwabara N, Ariyama H, Tanaka R, Baba E, Nakamura M, Harada M, Nakano S: Protection against methotrexate toxicity by a soybean protein- and omega-3 fatty acid-containing diet: comparative study with a casein-containing diet. Oncol Rep 2004, 12:41-45.
40. US Food and Drug Administration: Agency response letter GRAS notice no. GRN 000102. [http://www.cfsan.fda.gov/~rdb/opa-g102.html]
41. Bang HO, Dyerberg J, Sinclair HM: The composition of eskimo food in north western Greenland. Am J Clin Nutr 1980, 33: 2657-2661.
42. Kromann N, Green A: Epidemiological studies in the Upernavik district, Greenland. Acta Med Scand 1980, 208:401-406.
43. Cleland LG, James MJ, Keen H, Danda D, Caughey G, Proudman SM: Fish oil: an example of an anti-inflammatory food. Asia Pac J Clin Nutr 2005, Suppl:S66-S71.
44. Bacon PA, Townend JN: Nail in the coffin: Increasing evidence for the role of rheumatic disease in the cardiovascular mortality of rheumatoid arthritis. Arthritis Rheum 2001, 44:2707-2710.
45. Eritsland J, Arnesen H, Seljeflot I, Kierulf P: Long-term effects of n-3 polyunsaturated fatty acids on haemostatic variables and bleeding episodes in patients with coronary artery disease. Blood Coagul Fibrinolysis 1995, 6:17-22.
46. GISSI Prevenzione Investigators: Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet 1999, 354:447-455.
47. Smith KM, Sahyoun NR: Fish consumption: recommendations versus advisories, can they be reconciled? Nutr Rev 2005, 63: 39-46.
48. Bolger PM, Schwetz BA: Mercury and health. N Engl J Med 2002, 347:1735-1736.
49. Melanson SF, Lewandrowski EL, Flood JG, Lewandrowski KB: Measurement of organochlorines in commercial over-the-counter fish oil preparations: implications for dietary and therapeutic recommendations for omega-3 fatty acids and a review of the literature. Arch Pathol Lab Med 2005, 129:74-77.
50. Shapiro JA, Koepsell TD, Voigt LF, Dugowson CE, Kestin M, Nelson JL: Diet and rheumatoid arthritis in women: a possible protective effect of fish consumption. Epidemiol 1996, 7:256-263.
51. Shichikawa K, Takenaka Y, Maeda A, Yoshino R, Tsujimoto M, Ota H, Kashiwade T, Hongo I: A longitudinal population survey of rheumatoid arthritis in a rural district in Wakayama. The Ryumachi 1981, Suppl:35-43.
52. Welinder L, Graugaard B, Madsen M: HLA antigen and gene frequencies in Eskimos of East Greenland. Eur J Immunogenet 2000, 27:93-97.
53. Grimminger F, Mayser P, Papavassilis C, Thomas M, Schlotzer E, Heuer KU, Fuhrer D, Hinsch KD, Walmrath D, Schill WB, et al.: A double-blind, randomized, placebo-controlled trial of n-3 fatty acid based lipid infusion in acute, extended guttate psoriasis. Rapid improvement of clinical manifestations and changes in neutrophil leukotriene profile. Clin Investig 1993, 71:634-643.
54. Mayser P, Mrowietz U, Arenberger P, Bartak P, Buchvald J, Christophers E, Jablonska S, Salmhofer W, Schill WB, Kramer HJ, et al.: Omega-3 fatty acid-based lipid infusion in patients with chronic plaque psoriasis: results of a double-blind, randomized, placebo-controlled, multicenter trial. J Am Acad Dermatol 1998, 38-539-547.
55. Mayser P, Grimm H, Grimminger F: n-3 fatty acids in psoriasis. Br J Nutr 2002, Suppl:S77-82.
56. Walton AJ, Snaith ML, Locniskar M, Cumberland AG, Morrow WJ, Isenberg DA: Dietary fish oil and the severity of symptoms in patients with systemic lupus erythematosus. Ann Rheum Dis 1991, 50:463-466.
57. Leaf A: The electrophysiological basis for the antiarrhythmic actions of polyunsaturated fatty acids. Eur Heart J Suppl 2001, Suppl D:D98-D105.
58. McLennan PL, Abeywardena MY, Charnock JS: Dietary fish oil prevents ventricular fibrillation following coronary artery occlusion and reperfusion. Am Heart J 1988, 116:709-717.
59. Billman GE, Kang JX, Leaf A: Prevention of sudden cardiac death by dietary pure w-3 polyunsaturated fatty acids in dogs. Circulation 1999, 99:2452-2457.
60. Burr ML, Fehily AM, Gilbert JF, Rogers S, Holliday RM, Sweetnam PM, Elwood PC, Deadman NM: Effect of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART). Lancet 1989, 334:757-761.
61. de Lorgeril M, Renaud S, Mamelle N, Salen P, Martin JL, Monjaud I, Guidollet J, Touboul P, Delaye J: Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease. Lancet 1994, 343:1454-1459.
62. Din JN, Newby DE, Flapan AD: Omega 3 fatty acids and cardiovascular disease-fishing for a natural treatment. BMJ 2004, 328:30-35.
63. Studer M, Briel M, Leimenstoll B, Glass TR, Bucher HC: Effect of different antilipidemic agents and diets on mortality: a systematic review. Arch Intern Med 2005, 165:725-730.